MediWound Ltd. (MDWD) stock

MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30

$12.97−0.85 (-6.15%)

Close on Nov 12, 2026Market cap $166.47MP/E –Yield –

MediWound ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -$23.41M. The highest annual figure on record is $5.64M in fiscal 2019.

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$23.41M	–
FY2024	Dec 31, 2024	-$17.92M	–
FY2023	Dec 31, 2023	-$13.99M	–
FY2022	Dec 31, 2022	-$7.07M	–
FY2021	Dec 31, 2021	-$9.98M	–
FY2020	Dec 31, 2020	-$7.75M	-237.4%
FY2019	Dec 31, 2019	$5.64M	–
FY2018	Dec 31, 2018	-$3.38M	–
FY2017	Dec 31, 2017	-$13.12M	–
FY2016	Dec 31, 2016	-$19.57M	–
FY2015	Dec 31, 2015	-$20.72M	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	-$9.06M	–
Q2 FY2025	Jun 30, 2025	-$5.32M	–
Q2 FY2024	Jun 30, 2024	-$4.13M	–
Q2 FY2023	Jun 30, 2023	-$3.69M	-126.0%
Q2 FY2022	Jun 30, 2022	-$3.35M	–
Q2 FY2021	Jun 30, 2021	-$2.58M	–
Q2 FY2020	Jun 30, 2020	-$2.44M	–
Q2 FY2019	Jun 30, 2019	$14.22M	–
Q2 FY2018	Jun 30, 2018	-$3.12M	–
Q2 FY2017	Jun 30, 2017	-$3.56M	–